China Universal Asset Management Co., Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,031 shares of RYTM stock, worth $738,727. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,031
Previous 11,758
10.83%
Holding current value
$738,727
Previous $616,000
18.18%
% of portfolio
0.07%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding RYTM
# of Institutions
214Shares Held
66.7MCall Options Held
454KPut Options Held
57K-
Black Rock Inc. New York, NY6.74MShares$382 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$373 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$345 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$345 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$209 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.16B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...